Advisory Services Network’s Enanta Pharmaceuticals ENTA Stock Holding History

Advisory Services Network’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51	Buy	+4	New	+$54	﹤0.01%	4757
2025 Q4	–	Sell	-4	Closed	-$48	–	2529
2025 Q3	$48	Buy	+4	New	+$32	﹤0.01%	4467
2020 Q4	–	Sell	-262	Closed	-$12K	–	3401
2020 Q3	$12K	Buy	+262	New	+$12.7K	﹤0.01%	2325
2016 Q3	$8K	Buy	+300	New	+$6.97K	﹤0.01%	1372

Other funds holding ENTA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SSC

Spruce Street Capital New York $416M AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Advisory Services Network's ENTA Position: Q1 2026 in Review

Advisory Services Network opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 4 shares worth $51. The stake represents ﹤0.01% of the portfolio and ranks #4757 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in ENTA as recently as Q3 2025.

Advisory Services Network first reported a position in ENTA in Q3 2016 and has held it in 4 quarters since. The position peaked at $12K in Q3 2020. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

Advisory Services Network held 4 shares of Enanta Pharmaceuticals worth $51 as of Q1 2026.
Enanta Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
Enanta Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4757 holding.
Advisory Services Network first reported a position in Enanta Pharmaceuticals in Q3 2016 and has held it in 4 quarters since.
Advisory Services Network's Enanta Pharmaceuticals position peaked at $12K in Q3 2020.
132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.